Trial · NCT01539226
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| HIV-1 Seroconversion According to Comprehensive HIV Testing Algorithm. | Dapivirine Vaginal Ring | 82 | Participants | ||
| HIV-1 Seroconversion According to Comprehensive HIV Testing Algorithm. | Placebo Vaginal Ring | 61 | Participants | ||
| All Adverse Events | Dapivirine Vaginal Ring | 1147 | Participants | ||
| All Adverse Events | Placebo Vaginal Ring | 561 | Participants | ||
| The Incidence Rate of HIV-2 Seroconversion. | Dapivirine Vaginal Ring | 0 | Participants | ||
| The Incidence Rate of HIV-2 Seroconversion. | Placebo Vaginal Ring | 0 | Participants | ||
| The Incidence of Curable STIs | Dapivirine Vaginal Ring | 682 | Participants | ||
| The Incidence of Curable STIs | Placebo Vaginal Ring | 315 | Participants | ||
| Percentage of Participants With Pregnancy in Each Trial Arm Over the IP Use Period; | Dapivirine Vaginal Ring | 43 | Participants | ||
| Percentage of Participants With Pregnancy in Each Trial Arm Over the IP Use Period; | Placebo Vaginal Ring | 20 | Participants | ||
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 4 | 77.1 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 8 | 76.5 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 12 | 75.0 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 16 | 74.9 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 20 | 73.7 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 24 | 73.9 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 28 | 73.4 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 32 | 73.5 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 36 | 74.9 | percentage of participants with data | |
| The Percentage of Women Who Report Adherence to the Use of the Vaginal Ring Inserted Once Every 4 Weeks Over the Trial Period; | Dapivirine Vaginal Ring | Week 40 | 76.1 | percentage of participants with data |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01539226/results